Immune Gene Signatures and Immunotypes in Immune Microenvironment Are Associated With Glioma Prognose

by Cao, H., Chao, M., Deng, S.-Z, Guo, S., Han, L., Hu, Y., Jiao, Y., Li, C., Mou, Y., Wang, L., Wang, X.-X, Xue, G., Zhai, Y., Zhang, H.-M, Zhao, W.
Published 2022

Implications of IDH mutations on immunotherapeutic strategies for malignant glioma

by Choi, B.D, Curry, W.T, Kitagawa, Y., Miller, J.J, Richardson, L.G, Wakimoto, H.
Published 2022

The immune cell atlas of human neuroblastoma

by Baryawno, N., Fard, S.S, Gisselsson, D., Gustafsson, K., Hagerling, C., Johnsen, J.I, Kharchenko, P.V, Kogner, P., Lindström, A., Mei, S., Olsen, T.K, Valind, A., Verhoeven, B.M
Published 2022

Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors

by Bedard, P.L, Brohl, A.S, Cunningham, R., Giobbie-Hurder, A., Hathaway, E., Manos, M., Rahma, O.E, Renouf, D.J, Rodig, S., Severgnini, M., Sharon, E., Stephen Hodi, F., Streicher, H., Tyan, K.
Published 2022

Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors

by Bell, A.T.F, Bialkowski, L., Çuburu, N., Kim, R., Lowy, D.R, Pontejo, S.M, Schiller, J.T, Sethi, S.K, Thompson, C.D
Published 2022

Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells

by Fan, Q., Huang, C., Kong, Q., Nice, E.C, Shi, Z., Tian, H., Zuo, J.
Published 2022

BUB1 predicts poor prognosis and immune status in liver hepatocellular carcinoma

by Bai, Y., Chen, H., Liu, L., Qi, W., Wang, Y., Yu, Y., Zhang, Y.
Published 2022

DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with...

by de Vos, L., Dietrich, D., Dietrich, J., Fietz, S., Fröhlich, A., Hoffmann, F., Kuster, P., Landsberg, J., Niebel, D., Ramírez Valladolid, S., Saavedra, G., Sirokay, J., Strieth, S., Vogt, T.J, Zarbl, R.
Published 2022

Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function

by Brennan, D., Chouchani, E.T, Doughty, M., Douglas, A., Dyck, L., Fabre, A., Heneghan, H., Hogan, A., Leroux, C., Loftus, R.M, Lynch, L., McCormack, J., Mills, E.L, Moran, B., O’shea, D., Prendeville, H., Raverdeau, M., Wilk, M.M, Wilkinson, M.
Published 2022

Characterization and Functional Analysis of Tumor-Derived Microparticles

by Huang, B., Ma, J., Tang, K., Wei, K., Zhang, H.
Published 2021

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models

by Aguilar, E., Aguilar, L.K, Barone, F., Chiocca, E.A, Griffith, A.M, Guzik, B.W, Koch, M.S, Lawler, S., Lederer, J.A, Nowicki, M.O, Tabatabai, G., Tak, P.P, Zdioruk, M.
Published 2022

Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors

by Boland, G.M, Cohen, S.
Published 2022

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

by Andreatta, M., Barras, D., Benedetti, F., Berthold, D.R, Bourhis, J., Carmona, S.J, Corria-Osorio, J., Coukos, G., Crespo, I., Dafni, U., de Olza, M.O, Dimopoulou, G., Dromain, C., Duran, R., Foukas, P., Genolet, R., Ghisoni, E., Harari, A., Herrera, F.G, Imbimbo, M., Irving, M., Kandalaft, L.E, Laniti, D.D, Messemaker, M., Orcurto, A., Pittet, M.J, Prior, J., Rodrigo, B.N, Ronet, C., Rusakiewicz, S., Sarivalasis, A., Schaefer, N., Sempoux, C., Smith, T., Spill, A., Tsourti, Z., Warren, S.E, Zaman, K., Zimmermann, S.
Published 2022

Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen

by Bellile, E., Bryan Bell, R., Campos, C.Z, Cernea, C.R, Cruz, F.J.S.M, D'Silva, N., Erman, A., Girotto, G.C, Higgins, K., Kaplan, M., Kraus, D., Krempl, G., Liu, S., Martins, W.A, McCaul, J., Moyer, J., Newman, J., Nguyen, A., Nieva, J., Oliveira, F., Panwar, A., Patel, M., Rozek, L., Sartor, M.A, the INSPIRE Trial Clinical Investigators, Valentino, J., Victorina, A.P, Wolf, G.T, Zarins, K.
Published 2021

CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future

by Lim, M., Lin, Y.-J, Mashouf, L.A
Published 2022

G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes

by Colby, A.H, Colson, Y.L, Ding, H.-F, Grinstaff, M.W, Klement, J.D, Liu, K., Lu, C., Oberlies, N.H, Pearce, C.J, Shi, H., Yang, D.
Published 2022

Modular micro-physiological human tumor/tissue models based on decellularized tissue for improved preclinical testing

by Baur, F., Brähler, C., Dandekar, G., Dandekar, T., Fuchs, M., Göttlich, C., Kronenthaler, C., Kühnemundt, J., Kunz, M., Leifeld, H., Nelke, L.C, Nietzer, S.L, Peindl, M., Prelog, M., Scherg, F., Schmitt, M., Schmitt, T., Walles, H., Wischhusen, J.
Published 2021